NCT03847428 2026-03-06
EMERALD-2
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
28 trialsNCT05883644 2026-02-18
SIERRA
AstraZeneca
Phase 3 Active not recruiting
NCT03778957 2026-01-16
EMERALD-1
AstraZeneca
Phase 3 Active not recruiting
NCT03383458 2025-11-21
CheckMate 9DX
Bristol-Myers Squibb
Phase 3 Active not recruiting
NCT06680258 2025-09-03
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
Tempest Therapeutics
Phase 3 Not yet recruiting
NCT05201404 2025-04-29
LIVERATION
Can-Fite BioPharma
Phase 3 Recruiting
NCT00051545 2025-02-25
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
LEO Pharma
Phase 3 Terminated
NCT05301842 2025-01-15
EMERALD-3
AstraZeneca
Phase 3 Active not recruiting
NCT04340193 2024-11-26
CheckMate 74W
Bristol-Myers Squibb
Phase 3 Completed
NCT02112656 2024-08-20
OPTIMA
Imunon
Phase 3 Completed
NCT00617981 2024-05-03
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Imunon
Phase 3 Completed
NCT02435433 2023-01-20
REACH-2
Eli Lilly and Company
Phase 3 Completed
NCT01402908 2022-06-23
PATRON
Cellxpert Biotechnology Corp.
Phase 3 Terminated
NCT01908426 2021-05-06
CELESTIAL
Exelixis
Phase 3 Completed
NCT00825955 2019-10-09
BRISK PS
Bristol-Myers Squibb
Phase 3 Completed
NCT02232490 2019-02-26
Hepko-V5
Immunitor LLC
Phase 3 Unknown
NCT00692770 2018-08-08
STORM
Bayer
Phase 3 Completed
NCT00829413 2018-08-03
SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization
Bracco Diagnostics, Inc
Phase 3 Completed
NCT00788697 2017-12-12
SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization
Bracco Diagnostics, Inc
Phase 3 Completed
NCT02029157 2017-10-09
JET-HCC
Kyowa Kirin Co., Ltd.
Phase 3 Completed
NCT00440310 2015-08-25
Phase 3 Trial of Litxâ„¢ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
Light Sciences Oncology
Phase 3 Completed
NCT00355355 2015-01-30
A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Light Sciences Oncology
Phase 3 Completed
NCT00105443 2014-10-31
SHARP
Bayer
Phase 3 Completed
NCT00494299 2013-12-20
Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)
Bayer
Phase 3 Completed
NCT01009593 2012-09-10
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Abbott
Phase 3 Terminated
NCT00568308 2011-06-15
PATHWAY
Progen Pharmaceuticals
Phase 3 Terminated
NCT00143403 2010-09-28
Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer
Pfizer
Phase 3 Completed
NCT00307866 2009-05-18
Identification of Hepatic Lesions
Bayer
Phase 3 Completed